ArticleThe oncologist2022

Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes.

Yunbi Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.